Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myobloc for Sialorrhea in ALS
NCT00125203Phase 3Completed
- Sponsor
- UT Health San Antonio
- Start
- Jul 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sialorrhea comparing Myobloc with Placebo (2 arms). Primary endpoint: Global impression of change by subject at 8 weeks. Started Jul 2003; status: completed.
02
Drugs
botulinum toxin type b
03
Conditions
sialorrhea
Beyond the preview
Go deeper on NCT00125203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125203.